The E-health Application To Modify ORal Energy Intake and Measure Outcomes REmotely in ALS Clinical Trial (EAT MORE2)
NCT04051333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87
Last updated 2022-02-08
Summary
This is phase IIa feasibility and tolerability study of a mobile health (mHealth) application designed to study the effects of remote dietary counseling on disease progression and quality of life. The study will consist of two phases: Part I will consist of building and beta-testing the ALS Nutrition app and Part II will consist of enrolling a larger cohort of users into the app.
Conditions
Interventions
- DEVICE
-
ALS Nutrition App (MyDataHelps platform)
We have designed a mobile health app to provide nutritional counseling and to measure disease outcomes both through self-reported questionnaires and through passive data collection.
Sponsors & Collaborators
-
ALS Association
collaborator OTHER -
Massachusetts General Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-30
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- United States
Study Locations
More Related Trials
-
Clinical Trial of Ezogabine (Retigabine) in ALS Subjects
NCT02450552 ·Status: COMPLETED ·Phase: PHASE2
-
Mitochondrial Functions and Oxidative Stress in ALS Patients
NCT00331812 ·Status: UNKNOWN
-
T-regulatory Cells in ALS
NCT04055623 ·Status: UNKNOWN ·Phase: PHASE2
-
Methodology Study of Novel Outcome Measures to Assess Progression of ALS
NCT02611674 ·Status: COMPLETED
-
Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precision ALS Project
NCT06820008 ·Status: RECRUITING
-
Early Feasibility Study of the MyoRegulator® for Treatment of ALS
NCT06165172 ·Status: COMPLETED ·Phase: NA
-
Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
NCT01884571 ·Status: COMPLETED ·Phase: PHASE2
-
Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis
NCT02447952 ·Status: COMPLETED ·Phase: NA
-
Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
NCT01730716 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate the Performance of a Diagnostic Test in ALS
NCT02759913 ·Status: UNKNOWN
-
Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis
NCT02559869 ·Status: COMPLETED
-
A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT03160898 ·Status: COMPLETED ·Phase: PHASE2
-
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
NCT06649955 ·Status: RECRUITING ·Phase: NA
-
Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials
NCT00620698 ·Status: COMPLETED
-
Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT01933321 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)
NCT00330681 ·Status: COMPLETED ·Phase: PHASE3
-
Home-based Remote Digital Monitoring to Assess ALS Progression (Track ALS)
NCT05276349 ·Status: COMPLETED
-
Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III
NCT00415519 ·Status: COMPLETED ·Phase: PHASE3
-
Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis
NCT03828123 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multiple Doses of AT-1501-A201 in Adults With ALS
NCT04322149 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation
NCT02794857 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS
NCT05349721 ·Status: TERMINATED ·Phase: PHASE2
-
Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00424463 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS
NCT02017912 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
NCT00677768 ·Status: COMPLETED